A detailed history of Baird Financial Group, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 29,968 shares of ILMN stock, worth $4.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,968
Previous 36,680 18.3%
Holding current value
$4.08 Million
Previous $3.83 Million 2.06%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$105.28 - $135.9 $706,639 - $912,160
-6,712 Reduced 18.3%
29,968 $3.91 Million
Q2 2024

Aug 13, 2024

BUY
$101.05 - $133.57 $69,724 - $92,163
690 Added 1.92%
36,680 $3.83 Million
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $7.88 Million - $9.08 Million
-61,681 Reduced 63.15%
35,990 $4.94 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $1.11 Million - $1.7 Million
11,914 Added 13.89%
97,671 $13.6 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $5.4 Million - $8.07 Million
41,911 Added 95.59%
85,757 $11.8 Million
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $5.72 Million - $7.26 Million
-31,203 Reduced 41.58%
43,846 $8.22 Million
Q1 2023

May 15, 2023

BUY
$193.75 - $232.55 $172,243 - $206,736
889 Added 1.2%
75,049 $17.5 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $1.55 Million - $1.99 Million
8,751 Added 14.77%
68,014 $13 Million
Q2 2022

Aug 08, 2022

BUY
$181.58 - $368.0 $1.87 Million - $3.8 Million
10,320 Added 21.09%
59,263 $10.9 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $1.38 Million - $1.93 Million
4,548 Added 10.24%
48,943 $17.1 Million
Q4 2021

Feb 09, 2022

BUY
$347.28 - $421.83 $3.48 Million - $4.23 Million
10,026 Added 29.17%
44,395 $16.9 Million
Q3 2021

Nov 12, 2021

SELL
$405.61 - $524.84 $1.25 Million - $1.62 Million
-3,083 Reduced 8.23%
34,369 $13.9 Million
Q2 2021

Aug 11, 2021

BUY
$372.84 - $481.5 $3.46 Million - $4.47 Million
9,281 Added 32.95%
37,452 $17.7 Million
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $2.96 Million - $4.14 Million
-8,195 Reduced 22.53%
28,171 $10.8 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $8.82 Million - $11.2 Million
30,140 Added 484.1%
36,366 $13.5 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $102,839 - $153,483
383 Added 6.55%
6,226 $1.92 Million
Q2 2020

Oct 22, 2020

SELL
$256.46 - $373.01 $119,766 - $174,195
-467 Reduced 7.4%
5,843 $383,000
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $243,380 - $353,986
949 Added 17.7%
6,310 $500,000
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $34,727 - $55,697
166 Added 3.2%
5,361 $1.46 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $430,705 - $501,222
-1,494 Reduced 22.34%
5,195 $1.72 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $5.77 Million - $8.18 Million
-21,622 Reduced 76.37%
6,689 $391,000
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $1.02 Million - $1.24 Million
3,381 Added 13.56%
28,311 $10.4 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $281,019 - $331,136
1,031 Added 4.31%
24,930 $7.75 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $200,258 - $269,406
735 Added 3.17%
23,899 $7.17 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $423,303 - $556,830
1,517 Added 7.01%
23,164 $8.49 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $22.4 Million - $28.7 Million
-98,306 Reduced 81.95%
21,647 $6.05 Million
Q1 2018

May 14, 2018

SELL
$209.54 - $253.91 $1.26 Million - $1.53 Million
-6,037 Reduced 4.79%
119,953 $28.4 Million
Q4 2017

Feb 09, 2018

SELL
$202.23 - $230.03 $25.6 Million - $29.1 Million
-126,383 Reduced 50.08%
125,990 $27.5 Million
Q3 2017

Nov 14, 2017

SELL
$172.3 - $213.93 $2.08 Million - $2.58 Million
-12,047 Reduced 4.56%
252,373 $50.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
264,420
264,420 $45.9 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.